DBV Technologies publie ses résultats financiers annuels 2025 et fait le point sur ses activités
View original at globenewswire.com“Trésorerie et équivalents de trésorerie de 194 millions de dollars au 31 décembre 2025”
What we drew from this source
The claims Via News extracted from this document. We point to the source; we don't replace it.
DBV is pleased with the progress made in strengthening capabilities and building a company ready for the launch of Viaskin Peanut
60% confidenceThese estimates are based on the Company's current forecasts and exclude any additional expenses related to programs other than Viaskin Peanut, or resulting from potential licensing or acquisition operations of additional product candidates or technologies
60% confidenceThe Company may have based these estimates on assumptions that could prove to be inaccurate, and could consequently use its resources more quickly than anticipated
60% confidenceManagement estimates that the Company has sufficient resources to fund operations through the second quarter of 2027
60% confidenceDBV remains firmly committed to making Viaskin Peanut available to children aged 1 to 7 years allergic to peanuts
60% confidenceWe approached 2025 focused on strengthening the company's financial position, completing the VITESSE study, launching the COMFORT Toddlers study, and preparing for the BLA submission and potential commercial launch in the United States
60% confidence